156 related articles for article (PubMed ID: 8076666)
1. Inhibition of macrophage chemotaxis and peripheral nerve regeneration in normal and hyperglycemic rats by the aldose reductase inhibitor Tolrestat.
Calcutt NA; McMurray HF; Moorhouse DF; Bache M; Parthasarathy S; Powell HC; Mizisin AP
Exp Neurol; 1994 Aug; 128(2):226-32. PubMed ID: 8076666
[TBL] [Abstract][Full Text] [Related]
2. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
Cotter MA; Cameron NE; Hohman TC
J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
[TBL] [Abstract][Full Text] [Related]
3. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat.
Tao RV; Takahashi Y; Kador PF
Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of diabetic neuropathy--do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid formation in the rat sciatic nerves?
Colciago A; Negri-Cesi P; Celotti F
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):22-6. PubMed ID: 11835121
[TBL] [Abstract][Full Text] [Related]
5. Levocarnitine acetyl stimulates peripheral nerve regeneration and neuromuscular junction remodelling following sciatic nerve injury.
De Angelis C; Scarfò C; Falcinelli M; Reda E; Ramacci MT; Angelucci L
Int J Clin Pharmacol Res; 1992; 12(5-6):269-79. PubMed ID: 1338731
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase, diabetes, and thickening of the retinal inner limiting membrane.
Nagata M; Robison WG
Invest Ophthalmol Vis Sci; 1987 Nov; 28(11):1867-9. PubMed ID: 3117719
[TBL] [Abstract][Full Text] [Related]
7. A new approach against sugar cataract through aldose reductase inhibitors.
Banditelli S; Boldrini E; Vilardo PG; Cecconi I; Cappiello M; Dal Monte M; Marini I; Del Corso A; Mura U
Exp Eye Res; 1999 Nov; 69(5):533-8. PubMed ID: 10548473
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p38 MAP kinase activity enhances axonal regeneration.
Myers RR; Sekiguchi Y; Kikuchi S; Scott B; Medicherla S; Protter A; Campana WM
Exp Neurol; 2003 Dec; 184(2):606-14. PubMed ID: 14769353
[TBL] [Abstract][Full Text] [Related]
9. Impaired regeneration and no amelioration with aldose reductase inhibitor in crushed unmyelinated nerve fibers of diabetic rats.
Yasuda H; Terada M; Taniguchi Y; Sasaki T; Maeda K; Haneda M; Kashiwagi A; Kikkawa R
Neuroreport; 1999 Aug; 10(11):2405-9. PubMed ID: 10439472
[TBL] [Abstract][Full Text] [Related]
10. Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group.
Sima AA; Greene DA; Brown MB; Hohman TC; Hicks D; Graepel GJ; Bochenek WJ; Beg M; Gonen B
J Diabetes Complications; 1993; 7(3):157-69. PubMed ID: 8343610
[TBL] [Abstract][Full Text] [Related]
11. Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition.
Lambourne JE; Brown AM; Calcutt N; Tomlinson DR; Willars GB
Diabetologia; 1988 Jun; 31(6):379-84. PubMed ID: 2970984
[TBL] [Abstract][Full Text] [Related]
12. Tolrestat improves nerve regeneration after crush injury in streptozocin-induced diabetic rats.
Terada M; Yasuda H; Kikkawa R; Shigeta Y
Metabolism; 1996 Oct; 45(10):1189-95. PubMed ID: 8843171
[TBL] [Abstract][Full Text] [Related]
13. Effects of seven days of galactose feeding and aldose reductase inhibition on mast cells and vessel morphometry in rat sciatic nerve.
Brett FM; Kalichman MW; Calcutt NA; Mizisin AP
J Neurol Sci; 1996 Sep; 141(1-2):6-12. PubMed ID: 8880685
[TBL] [Abstract][Full Text] [Related]
14. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor.
Robison WG; Nagata M; Laver N; Hohman TC; Kinoshita JH
Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2285-92. PubMed ID: 2509395
[TBL] [Abstract][Full Text] [Related]
15. Reduced nerve blood flow in diabetic rats: relationship to nitric oxide production and inhibition of aldose reductase.
Tomlinson DR; Dewhurst M; Stevens EJ; Omawari N; Carrington AL; Vo PA
Diabet Med; 1998 Jul; 15(7):579-85. PubMed ID: 9686698
[TBL] [Abstract][Full Text] [Related]
16. Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve.
Robison WG; Nagata M; Tillis TN; Laver N; Kinoshita JH
Invest Ophthalmol Vis Sci; 1989 Nov; 30(11):2293-9. PubMed ID: 2509396
[TBL] [Abstract][Full Text] [Related]
17. Inhibiting effect of minocycline on the regeneration of peripheral nerves.
Keilhoff G; Langnaese K; Wolf G; Fansa H
Dev Neurobiol; 2007 Sep; 67(10):1382-95. PubMed ID: 17638380
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase inhibition, Doppler flux and conduction in diabetic rat nerve.
Calcutt NA; Mizisin AP; Kalichman MW
Eur J Pharmacol; 1994 Jan; 251(1):27-33. PubMed ID: 8137868
[TBL] [Abstract][Full Text] [Related]
19. Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy.
Sredy J; Sawicki DR; Notvest RR
J Diabet Complications; 1991; 5(1):42-7. PubMed ID: 1830318
[TBL] [Abstract][Full Text] [Related]
20. Tolrestat pharmacokinetics in rat peripheral nerve.
Dvornik D; Millen J; Hicks DR; Kraml M
J Diabetes Complications; 1994; 8(1):18-26. PubMed ID: 8167382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
